Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: E9AYS8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 290 | 292 | PF00675 | 0.565 |
CLV_NRD_NRD_1 | 93 | 95 | PF00675 | 0.501 |
CLV_PCSK_KEX2_1 | 106 | 108 | PF00082 | 0.372 |
CLV_PCSK_KEX2_1 | 93 | 95 | PF00082 | 0.510 |
CLV_PCSK_PC1ET2_1 | 106 | 108 | PF00082 | 0.371 |
CLV_PCSK_PC1ET2_1 | 93 | 95 | PF00082 | 0.489 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.443 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.481 |
CLV_PCSK_SKI1_1 | 281 | 285 | PF00082 | 0.539 |
DEG_APCC_DBOX_1 | 93 | 101 | PF00400 | 0.570 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.445 |
DEG_SPOP_SBC_1 | 172 | 176 | PF00917 | 0.765 |
DEG_SPOP_SBC_1 | 186 | 190 | PF00917 | 0.590 |
DOC_MAPK_gen_1 | 93 | 102 | PF00069 | 0.572 |
DOC_MAPK_MEF2A_6 | 93 | 102 | PF00069 | 0.597 |
DOC_PP1_RVXF_1 | 214 | 220 | PF00149 | 0.508 |
DOC_PP4_FxxP_1 | 116 | 119 | PF00568 | 0.631 |
DOC_PP4_FxxP_1 | 286 | 289 | PF00568 | 0.592 |
DOC_USP7_MATH_1 | 173 | 177 | PF00917 | 0.743 |
DOC_USP7_MATH_1 | 186 | 190 | PF00917 | 0.599 |
DOC_USP7_MATH_1 | 218 | 222 | PF00917 | 0.714 |
DOC_USP7_MATH_1 | 248 | 252 | PF00917 | 0.719 |
DOC_USP7_MATH_1 | 81 | 85 | PF00917 | 0.447 |
DOC_WW_Pin1_4 | 301 | 306 | PF00397 | 0.735 |
LIG_14-3-3_CanoR_1 | 3 | 11 | PF00244 | 0.440 |
LIG_BIR_III_4 | 269 | 273 | PF00653 | 0.670 |
LIG_FHA_1 | 143 | 149 | PF00498 | 0.717 |
LIG_FHA_1 | 182 | 188 | PF00498 | 0.694 |
LIG_FHA_1 | 221 | 227 | PF00498 | 0.635 |
LIG_FHA_1 | 250 | 256 | PF00498 | 0.667 |
LIG_FHA_1 | 37 | 43 | PF00498 | 0.380 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.419 |
LIG_FHA_2 | 252 | 258 | PF00498 | 0.701 |
LIG_Integrin_RGD_1 | 277 | 279 | PF01839 | 0.501 |
LIG_IRF3_LxIS_1 | 146 | 151 | PF10401 | 0.637 |
LIG_LIR_Gen_1 | 205 | 215 | PF02991 | 0.659 |
LIG_LIR_Nem_3 | 163 | 168 | PF02991 | 0.714 |
LIG_LIR_Nem_3 | 205 | 211 | PF02991 | 0.633 |
LIG_MYND_1 | 285 | 289 | PF01753 | 0.669 |
LIG_SH2_CRK | 165 | 169 | PF00017 | 0.730 |
LIG_SH2_STAP1 | 208 | 212 | PF00017 | 0.677 |
LIG_SH2_STAT5 | 238 | 241 | PF00017 | 0.631 |
LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.388 |
LIG_SH3_3 | 193 | 199 | PF00018 | 0.642 |
LIG_SH3_3 | 8 | 14 | PF00018 | 0.465 |
LIG_SH3_3 | 97 | 103 | PF00018 | 0.606 |
LIG_SH3_4 | 284 | 291 | PF00018 | 0.739 |
LIG_SUMO_SIM_anti_2 | 15 | 23 | PF11976 | 0.439 |
LIG_SUMO_SIM_anti_2 | 174 | 184 | PF11976 | 0.688 |
LIG_SUMO_SIM_anti_2 | 96 | 102 | PF11976 | 0.559 |
LIG_SUMO_SIM_par_1 | 143 | 151 | PF11976 | 0.687 |
LIG_SUMO_SIM_par_1 | 194 | 200 | PF11976 | 0.621 |
LIG_SUMO_SIM_par_1 | 223 | 231 | PF11976 | 0.620 |
LIG_UBA3_1 | 211 | 216 | PF00899 | 0.678 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.702 |
MOD_CK1_1 | 200 | 206 | PF00069 | 0.680 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.645 |
MOD_CK1_1 | 251 | 257 | PF00069 | 0.695 |
MOD_CK1_1 | 27 | 33 | PF00069 | 0.445 |
MOD_CK1_1 | 293 | 299 | PF00069 | 0.749 |
MOD_CK2_1 | 174 | 180 | PF00069 | 0.728 |
MOD_CK2_1 | 251 | 257 | PF00069 | 0.699 |
MOD_CK2_1 | 29 | 35 | PF00069 | 0.477 |
MOD_CK2_1 | 293 | 299 | PF00069 | 0.752 |
MOD_CK2_1 | 50 | 56 | PF00069 | 0.412 |
MOD_Cter_Amidation | 104 | 107 | PF01082 | 0.485 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.438 |
MOD_GlcNHglycan | 294 | 298 | PF01048 | 0.523 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.651 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.563 |
MOD_GSK3_1 | 217 | 224 | PF00069 | 0.617 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.456 |
MOD_GSK3_1 | 249 | 256 | PF00069 | 0.690 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.334 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.608 |
MOD_NEK2_1 | 181 | 186 | PF00069 | 0.678 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.670 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.378 |
MOD_OFUCOSY | 137 | 142 | PF10250 | 0.310 |
MOD_PKA_2 | 221 | 227 | PF00069 | 0.587 |
MOD_PKA_2 | 273 | 279 | PF00069 | 0.684 |
MOD_PKA_2 | 290 | 296 | PF00069 | 0.745 |
MOD_Plk_1 | 142 | 148 | PF00069 | 0.683 |
MOD_Plk_2-3 | 253 | 259 | PF00069 | 0.683 |
MOD_Plk_2-3 | 50 | 56 | PF00069 | 0.412 |
MOD_Plk_4 | 17 | 23 | PF00069 | 0.385 |
MOD_Plk_4 | 197 | 203 | PF00069 | 0.693 |
MOD_Plk_4 | 207 | 213 | PF00069 | 0.599 |
MOD_ProDKin_1 | 301 | 307 | PF00069 | 0.731 |
TRG_DiLeu_BaLyEn_6 | 144 | 149 | PF01217 | 0.680 |
TRG_DiLeu_BaLyEn_6 | 222 | 227 | PF01217 | 0.677 |
TRG_ENDOCYTIC_2 | 165 | 168 | PF00928 | 0.731 |
TRG_ENDOCYTIC_2 | 208 | 211 | PF00928 | 0.599 |
TRG_Pf-PMV_PEXEL_1 | 95 | 99 | PF00026 | 0.446 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HX16 | Leptomonas seymouri | 46% | 95% |
A0A3Q8IE36 | Leishmania donovani | 89% | 100% |
A4HFE5 | Leishmania braziliensis | 73% | 100% |
A4I2L5 | Leishmania infantum | 89% | 100% |
C9ZKW5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 84% |
E9AD03 | Leishmania major | 90% | 100% |